Dental South China International Expo Observation | CHIRIMEN's New Product for Edentulous Implant Restoration, Precision Scanning Process Shortened to 15 MinutesIssuing time:2026-03-04 15:32
On March 3, 2026, CHIRIMEN Company introduced in an interview that its new product at the exhibition is an edentulous scanning system. Its core product, the edentulous scanning abutment, integrated with an AI software platform, is a domestic first. Its advantage lies in simplifying the dental implant positioning process: it locates the dental implant position via the edentulous scanning abutment, offering high precision while saving steps and improving efficiency. According to the company's disclosure, clinical feedback shows the product has achieved zero rework in thousands of cases, indicating high reliability. Furthermore, the company stated that the product is compatible with intraoral scanners from different brands on the market, effectively reducing the operational costs for medical institutions. Zhilineng Technology Company indicated that after using this product, the clinical workflow is significantly shortened, with the complete installation and scanning process typically taking only about fifteen minutes. CHIRIMEN (Booth: Hall 18.2 L01): Shenzhen Zhilineng Technology Co., Ltd. is a national Class III medical device manufacturer, possessing multiple products with national Class III Medical Device Registration. The currently developed database covers over 90% of mainstream European, American, and Korean implant systems on the market. It can process Custom Abutments, Maryland bridges, bar attachments, monolithic crowns, etc., and can mass-produce implant system supporting products such as analogs, scanning abutments, millable abutment blanks, bases, healing abutments, etc. *This content was collected by DENTALGOODNEWS (Leading Dental Industry Media, DGN) special correspondent Zhao Shuang. Click here to visit DGN Global Edition to stay updated on the latest industry trends anytime.
Article classification:
New Products
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks.
Copyright © This Platform. Unauthorized reproduction & commercial use prohibited.
Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
|
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
|
